|
Focus on Hematology
Citations 11-20 of 29 total displayed.
|
Past content
(since Jan 1999):
|
Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
- Mario Arpinati, Cherie L. Green, Shelly Heimfeld, Jill E. Heuser, and Claudio Anasetti
Blood 2000; 95: 2484-2490.
[Abstract]
[Full text]
[PDF]
Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?
- Charles T. Esmon
Blood 2000; 95: 1113-1116.
[Full text]
[PDF]
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
- M. C. Minnema, A. C. K. Chang, P. M. Jansen, Y. T. P. Lubbers, B. M. Pratt, B. G. Whittaker, F. B. Taylor, C. E. Hack, and B. Friedman
Blood 2000; 95: 1117-1123.
[Abstract]
[Full text]
[PDF]
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
- Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, C. Erik Hack, Susan K. Paulson, Aziz Karim, Jozef Kesecioglu, Marcel Levi, Sander J. H. van Deventer, and Tom van der Poll
Blood 2000; 95: 1124-1129.
[Abstract]
[Full text]
[PDF]
Introduction: anti-adhesion therapy in sickle cell disease
- John M. Harlan
Blood 2000; 95: 365-367.
[Full text]
[PDF]
Monoclonal antibodies to  V 3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor
- D. K. Kaul, H. M. Tsai, X. D. Liu, M. T. Nakada, R. L. Nagel, and B. S. Coller
Blood 2000; 95: 368-374.
[Abstract]
[Full text]
[PDF]
Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity
- Jay N. Lozier, Mark E. Metzger, Robert E. Donahue, and Richard A. Morgan
Blood 1999; 94: 3968-3975.
[Abstract]
[Full text]
[PDF]
Reversible Expression of CD34 by Murine Hematopoietic Stem Cells
- Takashi Sato, Joseph H. Laver, and Makio Ogawa
Blood 1999; 94: 2548-2554.
[Abstract]
[Full text]
[PDF]
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
- Rajendra N. Damle, Tarun Wasil, Franco Fais, Fabio Ghiotto, Angelo Valetto, Steven L. Allen, Aby Buchbinder, Daniel Budman, Klaus Dittmar, Jonathan Kolitz, Stuart M. Lichtman, Philip Schulman, Vincent P. Vinciguerra, Kanti R. Rai, Manlio Ferrarini, and Nicholas Chiorazzi
Blood 1999; 94: 1840-1847.
[Abstract]
[Full text]
[PDF]
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
- Terry J. Hamblin, Zadie Davis, Anne Gardiner, David G. Oscier, and Freda K. Stevenson
Blood 1999; 94: 1848-1854.
[Abstract]
[Full text]
[PDF]
|
|
